Refine by:
-
Congressional Testimony on Mental Health Funding, Crisis Services, and Research and Treatment Innovation
Outside Witness Testimony from NAMI’s Chief Advocacy Officer to the Senate Subcommittee on Labor, Health and Human Services, Education and Related Agencies, requesting FY26 funding for 988 and the Community Mental Health Block Grant within SAMHSA and NIMH. -
Congressional Testimony on Mental Health Funding, Crisis Services, and Research and Treatment Innovation
Outside Witness Testimony from NAMI’s Chief Advocacy Officer to the House Labor-HHS-Education Appropriations Subcommittee, requesting FY26 funding for 988 and the Community Mental Health Block Grant within SAMHSA and NIMH. -
NAMI-led Introductory Letter to HHS Secretary Kennedy
Letter to HHS Secretary RFK Jr. to congratulate him on his confirmation, introduce the Mental Health Liaison Group, and encourage him to bring the voice of lived experience to the Make America Healthy Again (MAHA) Commission. -
Regulatory Comment to DOJ on Criminal Justice and Research and Treatment Innovation
Regulatory comment in support of the Bureau of Justice Assistance’s (BJA) proposed “Death in Custody Reporting Act Program Collection.” -
Regulatory Comment to the Bureau of Justice Statistics on Criminal Justice and Research and Treatment Innovation
Comment to the Bureau of Justice Statistics in support of efforts to collect information through the tool, “Capital Punishment Report of Inmates Under Sentence of Death,” and recommending the tool collect information on mental health treatment and diagnosis to document the disproportionate use of capital punishment toward people with serious mental illness. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation, Mental Health Funding and Criminal Justice
Letter to the House and Senate Appropriations Committees requesting the highest possible funding level in the FY 25 Commerce, Justice, Science Appropriations bill for the National Institute of Justice (NIJ) and Bureau of Justice Statistics (BJS) within the Department of Justice. -
Regulatory Comment to NCQA on Crisis Services and Research and Treatment Innovation
Regulatory comment supporting the NCQA’s Proposed Changes to Existing HEDIS Measures: Follow-Up After Emergency Department Visit for Mental Illness (FUM) and Follow-Up After Hospitalization for Mental Illness (FUH), and providing additional recommendations to strengthen the measures, including guidance on follow-up care. -
Letter to Congressional Committee Leadership on Research and Innovation & Criminal Justice
Letter to House and Senate Appropriations Committee leadership requesting $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health and $1 million for the National Institute of Justice to conduct public health research into firearm morbidity and mortality prevention. -
Regulatory Comment to the Office of Science and Technology Policy on Criminal Justice and Research and Treatment Innovation
Regulatory comment to White House Office of Science & Technology Policy in response to the RFI on “Advancing Effective, Accountable Policing and Criminal Justice Practices to Enhance Public Trust and Public Safety.” -
Regulatory Comment to SAMHSA on Research and Innovation Treatment & Crisis Services
Regulatory comments to SAMHSA Assistant Secretary Delphin-Rittmon, in response to the Revised Draft of the Updated Certification Criteria for the Certified Community Behavioral Health Clinics (CCBHC).
1
2
Next
